NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 760 filers reported holding NOVARTIS A G in Q2 2013. The put-call ratio across all filers is 0.60 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $3,963,000 | +5.8% | 54,404 | +14.7% | 0.07% | +4.3% |
| Q3 2016 | $3,745,000 | -4.1% | 47,434 | +0.2% | 0.07% | -5.5% |
| Q2 2016 | $3,905,000 | +15.1% | 47,336 | +1.0% | 0.07% | +9.0% |
| Q1 2016 | $3,394,000 | -24.3% | 46,857 | -10.1% | 0.07% | -25.6% |
| Q4 2015 | $4,484,000 | -6.5% | 52,121 | -0.1% | 0.09% | -10.0% |
| Q3 2015 | $4,797,000 | +85.9% | 52,189 | +98.9% | 0.10% | +92.3% |
| Q2 2015 | $2,580,000 | -0.3% | 26,233 | 0.0% | 0.05% | +4.0% |
| Q1 2015 | $2,587,000 | -23.7% | 26,233 | -28.3% | 0.05% | -26.5% |
| Q4 2014 | $3,391,000 | -2.5% | 36,594 | -1.0% | 0.07% | -5.6% |
| Q3 2014 | $3,479,000 | +0.8% | 36,960 | -3.1% | 0.07% | +1.4% |
| Q2 2014 | $3,452,000 | -99.9% | 38,126 | +11.3% | 0.07% | +14.5% |
| Q1 2014 | $2,913,550,000 | +91984.4% | 34,269 | -13.0% | 0.06% | -12.7% |
| Q4 2013 | $3,164,000 | -99.9% | 39,369 | -3.4% | 0.07% | -4.1% |
| Q3 2013 | $3,127,467,000 | +108379.6% | 40,770 | 0.0% | 0.07% | -1.3% |
| Q2 2013 | $2,883,000 | – | 40,770 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |